Funder: Foundation for Prader-Willi Research
Due Dates: February 27, 2026 (Letter of Intent) | May 15, 2026 (Full proposal)
Funding Amounts: Up to $150,000 in direct costs for 18 months; possible renewal for a second 18-month term; up to 8% indirect costs allowed.
Summary: Supports innovative research to advance understanding and treatment of Prader-Willi and Schaaf-Yang syndromes, with priority on genetics, neurobiology, clinical care, and therapeutic development.